Jingchun Wang
Overview
Explore the profile of Jingchun Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Y, Chen Y, Zhang J, Wang J, Yang S, Zhao H, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2411888.
PMID: 39903758
Metastasis remains a significant challenge in the treatment of hepatocellular carcinoma (HCC). The role of ribonuclease T2 (RNASET2) in HCC is still uncertain, although it has been reported to have...
2.
Han M, Wang J, Wu Y, Liao J, Guo J, Tang Z
Int J Biol Macromol
. 2025 Jan;
298:140080.
PMID: 39837449
Background: The role of inflammation in the development of type 2 diabetes mellitus (T2DM) related skin complications necessitates further investigation. This study aims to explore the correlation between inflammation and...
3.
Li L, Wang J, Ren S, Hao X
Neurosurg Rev
. 2024 Nov;
47(1):858.
PMID: 39560705
Prolyl 4-hydroxylase subunit alpha 2 (P4HA2), a key enzyme modulating the post-transcription of proteins, was reported to be a causative gene in IA. Nevertheless, the exact function and mechanism of...
4.
Wang J, Fan D, Cai D, Jin Y
Int J Biol Macromol
. 2024 Nov;
282(Pt 5):137105.
PMID: 39486702
Targeting and suppressing the malignant growth and metastasis of breast cancer has been challenging for years. Herein, a nanocarrier based on hyaluronic acid (HA)-modified cationic liposomes was developed for targeted...
5.
Wang J, Chen Y, Xu Y, Zhang J, Yang S, Zhou Y, et al.
Theranostics
. 2024 Oct;
14(17):6798-6817.
PMID: 39479454
The introduction of combination therapy utilizing tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors for advanced hepatocellular carcinoma (HCC) has significantly altered the management of affected patients. However, the absence...
6.
Ren R, Chen Y, Zhou Y, Shen L, Chen Y, Lei J, et al.
Genes Dis
. 2024 Sep;
11(6):101281.
PMID: 39281833
Dysregulated calcium (Ca) signaling pathways are associated with tumor cell death and drug resistance. In non-excitable cells, such as hepatocellular carcinoma (HCC) cells, the primary pathway for Ca influx is...
7.
Wang J, San Vicente Veliz J, Meuwly M
J Phys Chem A
. 2024 Jul;
128(39):8322-8332.
PMID: 39052035
The atom-exchange and atomization dissociation dynamics for the N(S) + N(Σ) reaction are studied using a reproducing kernel Hilbert space (RKHS)-based, global potential energy surface (PES) at the MRCI-F12/aug-cc-pVTZ-F12 level...
8.
Xie H, Wang J, Lou Z, Hu L, Segawa S, Kang X, et al.
J Am Chem Soc
. 2024 Jun;
146(27):18350-18359.
PMID: 38937461
The development of luminescent materials via mechanochemistry embodies a compelling yet intricate frontier within materials science. Herein, we delineate a methodology for the synthesis of brightly luminescent polymers, achieved by...
9.
Yang S, Zheng L, Li L, Zhang J, Wang J, Zhao H, et al.
Clin Transl Med
. 2024 May;
14(6):e1727.
PMID: 38804617
Background: The liver is anatomically divided into eight segments based on the distribution of Glisson's triad. However, the molecular mechanisms underlying each segment and its association with hepatocellular carcinoma (HCC)...
10.
Li G, Bao Y, Zhang H, Wang J, Wu X, Yan R, et al.
J Colloid Interface Sci
. 2024 May;
668:618-633.
PMID: 38696990
Tumor metastasis and recurrence are closely related to immune escape and hypoxia. Chemodynamic therapy (CDT), photodynamic therapy (PDT), and photothermal therapy (PTT) can induce immunogenic cell death (ICD), and their...